Significance of oxidative stress and antioxidant capacity tests as biomarkers of premature ovarian insufficiency: A case control study - PubMed
- ️Mon Jan 01 2024
Significance of oxidative stress and antioxidant capacity tests as biomarkers of premature ovarian insufficiency: A case control study
Kaoru Kakinuma et al. World J Clin Cases. 2024.
Abstract
Background: Premature ovarian insufficiency (POI) is a condition that causes secondary amenorrhea owing to ovarian hypofunction at an early stage. Early follicular depletion results in intractable infertility, thereby considerably reducing the quality of life of females. Given the continuum in weakened ovarian function, progressing from incipient ovarian failure (IOF) to transitional ovarian failure and further to POI, it is necessary to develop biomarkers for predicting POI. The oxidative stress states in IOF and POI were comprehensively evaluated via oxidative stress [diacron-reactive oxygen metabolites (d-ROMs)] test and antioxidant capacity [biological antioxidant potential (BAP)].
Aim: To explore the possibilities of oxidative stress and antioxidant capacity as biomarkers for the early detection of POI.
Methods: Females presenting with secondary amenorrhea over 4 mo and a follicle stimulating hormone level of > 40 mIU/mL were categorized into the POI group. Females presenting with a normal menstrual cycle and a follicle stimulating hormone level of > 10.2 mIU/mL were categorized into the IOF group. Healthy females without ovarian hypofunction were categorized into the control group. Among females aged < 40 years who visited our hospital from January 2021 to June 2022, we recruited 11 patients into both POI and IOF groups. For the potential antioxidant capacity, the relative oxidative stress index (BAP/d-ROMs × 100) was calculated, and the oxidative stress defense system was comprehensively evaluated.
Results: d-ROMs were significantly higher in the POI and IOF groups than in the control group, (478.2 ± 58.7 U.CARR, 434.5 ± 60.6 U.CARR, and 341.1 ± 35.1 U.CARR, respectively) (U.CARR is equivalent to 0.08 mg/dL of hydrogen peroxide). However, no significant difference was found between the POI and IOF groups. Regarding BAP, no significant difference was found between the control, IOF, and POI groups (2078.5 ± 157.4 μmol/L, 2116.2 ± 240.2 μmol/L, and 2029.0 ± 186.4 μmol/L, respectively). The oxidative stress index was significantly higher in the POI and IOF groups than in the control group (23.7 ± 3.3, 20.7 ± 3.6, and 16.5 ± 2.1, respectively). However, no significant difference was found between the POI and IOF groups.
Conclusion: High levels of oxidative stress suggest that evaluating the oxidative stress state may be a useful indicator for the early detection of POI.
Keywords: Biological antioxidant potential; Biomarker; Diacron-reactive oxygen metabolites test; Infertility; Oxidative stress; Premature ovarian insufficiency.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors declare that they have no conflicts of interest related to the manuscript.
Figures
Similar articles
-
Analysis of oxidative stress and antioxidative potential in premature ovarian insufficiency.
Kakinuma K, Kakinuma T. Kakinuma K, et al. World J Clin Cases. 2023 Apr 26;11(12):2684-2693. doi: 10.12998/wjcc.v11.i12.2684. World J Clin Cases. 2023. PMID: 37214574 Free PMC article.
-
Matsuura T, Kaneko H, Takayama K, Shibata R, Kataoka K, Ito S, Tsunekawa T, Shimizu H, Suzumura A, Namba R, Ito Y, Murohara T, Terasaki H. Matsuura T, et al. BMC Ophthalmol. 2020 Feb 18;20(1):56. doi: 10.1186/s12886-020-01334-y. BMC Ophthalmol. 2020. PMID: 32070305 Free PMC article.
-
Effects of mode of delivery on pro-oxidant/antioxidant balance in fetal circulation.
Kobayashi H, Iorio EL, Yoshino A. Kobayashi H, et al. J Matern Fetal Neonatal Med. 2019 Oct;32(19):3294-3299. doi: 10.1080/14767058.2018.1526911. Epub 2018 Oct 29. J Matern Fetal Neonatal Med. 2019. PMID: 30231659
-
The Role of Lifestyle and Dietary Factors in the Development of Premature Ovarian Insufficiency.
Shelling AN, Ahmed Nasef N. Shelling AN, et al. Antioxidants (Basel). 2023 Aug 11;12(8):1601. doi: 10.3390/antiox12081601. Antioxidants (Basel). 2023. PMID: 37627595 Free PMC article. Review.
-
Genes involved in the pathogenesis of premature ovarian insufficiency.
Orlandini C, Regini C, Vellucci FL, Petraglia F, Luisi S. Orlandini C, et al. Minerva Ginecol. 2015 Oct;67(5):421-30. Epub 2015 Jun 26. Minerva Ginecol. 2015. PMID: 26112693 Review.
References
-
- National Collaborating Centre for Women’s and Children’s Health. Menopause. Nov 12, 2015. [cited 26 October 2022]. Available from: https://www.nice.org.uk/guidance/ng23/evidence/full-guideline-559549261 .
-
- van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483–492. - PubMed
-
- Fraison E, Crawford G, Casper G, Harris V, Ledger W. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online. 2019;39:467–476. - PubMed
-
- Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–606. - PubMed
LinkOut - more resources
Full Text Sources